Passage Bio Inc — Quarterly Financial Statistics (NASDAQ:PASG) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -8.44 M-13.85 M-6.33 M-4.85 M-6.48 M -31.51 M Cash from investing activities 13.68 M39.63 M585 K00 40.22 M Cash from financing activities 47 K8.74 M85 K09 000 — Free cash flow -8.46 M-13.85 M-6.33 M-4.85 M-6.48 M -31.51 M

Nouvelles

Baird initie la couverture de Passage Bio avec une recommandation surperformance

Oppenheimer initie la couverture de Passage Bio avec une recommandation surperformance

Lucid Capital Markets initie la couverture de Passage Bio avec une recommandation d’achat

Lucid Capital Markets initiates Passage Bio stock with Buy rating

Monday’s Insider Moves: Key Buys and Sells in US Stocks Revealed

Lynx1 Capital achète des actions de Passage Bio (PASG) pour 223.734$

Lynx1 Capital buys Passage Bio (PASG) shares worth $223,734

Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet

Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade

Guggenheim lowers Passage Bio stock price target to $10 from $40

Canaccord Genuity lowers Passage Bio stock price target to $67 from $260

Lynx1 capital buys Passage Bio (PASG) shares worth $733,825